Search for other papers by Natsuko Watanabe in
Google Scholar
PubMed
Search for other papers by Jaeduk Yoshimura Noh in
Google Scholar
PubMed
Search for other papers by Naomi Hattori in
Google Scholar
PubMed
Search for other papers by Kenji Iwaku in
Google Scholar
PubMed
Search for other papers by Nami Suzuki in
Google Scholar
PubMed
Search for other papers by Ai Yoshihara in
Google Scholar
PubMed
Search for other papers by Hidemi Ohye in
Google Scholar
PubMed
Search for other papers by Miho Suzuki in
Google Scholar
PubMed
Search for other papers by Masako Matsumoto in
Google Scholar
PubMed
Search for other papers by Kei Endo in
Google Scholar
PubMed
Search for other papers by Yo Kunii in
Google Scholar
PubMed
Search for other papers by Gen Takagi in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
cardiovascular prognosis negatively [ 17 - 19 ]. Determining how thyrotoxicosis affects levels of cardiac troponin, which are indicative of minor myocardial damage, is an informative pursuit. However, a small investigation that measured cardiac troponin levels in
Search for other papers by Annelies Tonnelier in
Google Scholar
PubMed
Search for other papers by Jeroen de Filette in
Google Scholar
PubMed
Search for other papers by Ann De Becker in
Google Scholar
PubMed
Search for other papers by Sophie Deweer in
Google Scholar
PubMed
Search for other papers by Brigitte Velkeniers in
Google Scholar
PubMed
intracellular thyroid hormones into the circulation, which are bound onto new binding sites provided by the plasma or albumin replacement solution, thereby effectively decreasing the total thyroid hormone concentrations. In this report, thyroid hormone levels
Search for other papers by John H. Lazarus in
Google Scholar
PubMed
concentration of approximately 150 µg/l [ 10 ]. Although there has been a significant increase in the use of universal salt iodisation in the last 20 years, some countries, including for example the United Kingdom [ 11 ], are still iodine-deficient. Table
Search for other papers by Mathieu Spaas in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by Annouschka Laenen in
Google Scholar
PubMed
Search for other papers by Jaak Billen in
Google Scholar
PubMed
Search for other papers by Sandra Nuyts in
Google Scholar
PubMed
of DTC usually consists of total thyroidectomy followed by radioactive iodine (RAI) remnant ablation (RRA). Postoperative administration of RAI serves three major goals: the first is to destroy any residual microscopic disease as well as any remaining
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Federica Brozzi in
Google Scholar
PubMed
Search for other papers by Pierina Santini in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
for the management of high-risk patients in whom this procedure has shown a positive impact on recurrence and survival [ 15 , 16 ]. A selective use of RRA is proposed for the IR patients taking into account the level of risk of recurrence as well as
Search for other papers by Sara Monteiro-Martins in
Google Scholar
PubMed
Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by Rosalie B T M Sterenborg in
Google Scholar
PubMed
Search for other papers by Oleg Borisov in
Google Scholar
PubMed
Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany
Search for other papers by Nora Scherer in
Google Scholar
PubMed
Search for other papers by Yurong Cheng in
Google Scholar
PubMed
Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by Marco Medici in
Google Scholar
PubMed
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Search for other papers by Anna Köttgen in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Alexander Teumer in
Google Scholar
PubMed
required in the iodination process and H 2 O 2 production to form thyroid hormones ( 1 ). Additionally, a previous study showed that on continuous daily administration of calcium channel blockers, a gradual fall in levels of T3 and T4 with a rise in TSH
Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed
Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed
Search for other papers by George A. Vagenakis in
Google Scholar
PubMed
Search for other papers by Fotini N. Lamari in
Google Scholar
PubMed
Search for other papers by Efthymia Pitsi in
Google Scholar
PubMed
Search for other papers by Maria Eliopoulou in
Google Scholar
PubMed
Search for other papers by Nicholas G. Beratis in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
concentrations and suppressed TSH levels, discrimination between AIT1 and AIT2 in order to select the appropriate treatment is often challenging. AIT1 involves excessive thyroid hormone synthesis by autonomously functioning thyroid tissue, which typically occurs
Search for other papers by Fabián Pitoia in
Google Scholar
PubMed
Search for other papers by Erika Abelleira in
Google Scholar
PubMed
Search for other papers by Graciela Cross in
Google Scholar
PubMed
(7th ed.) [ 37 ]. All these patients were classified as being at an intermediate or high risk of recurrence. For inclusion, patients had to present a diagnosis of papillary thyroid cancer (PTC), be older than 18 years and have an undetectable level
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Laura Croce in
Google Scholar
PubMed
Search for other papers by Fausta Beneventi in
Google Scholar
PubMed
Search for other papers by Federica Ripepi in
Google Scholar
PubMed
Search for other papers by Irene De Maggio in
Google Scholar
PubMed
Search for other papers by Alberto Malovini in
Google Scholar
PubMed
Search for other papers by Camilla Bellingeri in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Marsida Teliti in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Arsenio Spinillo in
Google Scholar
PubMed
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Pavia (PV), Italy
Search for other papers by Flavia Magri in
Google Scholar
PubMed
offspring in these women ( 4 , 5 ), other authors did not describe any association ( 6 ). In this complicated scenario, identifying any possible cause leading to an increase in serum TSH levels during pregnancy that is not due to thyroid autoimmunity
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Laura Pierotti in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Cremolini in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Antonio Chella in
Google Scholar
PubMed
Search for other papers by Andrea Antonuzzo in
Google Scholar
PubMed
Search for other papers by Daniele Sgrò in
Google Scholar
PubMed
Search for other papers by Lucia Antonangeli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
/mL) Positive 0 0 Level TRAb (<1.5 IU/mL) Positive 0 0 Urinary iodine (100–300 μg/L) 214.2 (180–278) 218.5 (179–287) 0.11 Thyroglobulin (<30 ng/mL) 60.3 (11–480) 51 (6–550) 0